Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas - Archive ouverte HAL Access content directly
Journal Articles Acta Dermato-Venereologica Year : 2022

Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas

, , , (1) , , ,
1
Joséphine Franceschi
  • Function : Author
Marine Ehret
  • Function : Author
Laetitia Visseaux
  • Function : Author
Coralie Barbe
  • Function : Author
Éric Durot
  • Function : Author
Florent Grange
  • Function : Author

Abstract

Aggressive primary cutaneous T-cell lymphomas include advanced-stage mycosis fungoides (stage ≥ IIB mycosis fungoides), Sézary syndrome, gamma/delta cutaneous lymphoma, nasal type lymphoma, aggressive epidermotropic CD8+ T-cell lymphoma and some cutaneous lymphomas not otherwise specified. To evaluate their long-term prognosis, we conducted a retrospective cohort study of 85 patients diagnosed between 2005 and 2020 with advanced-stage mycosis fungoides (n = 48), Sézary syndrome (n = 28) or aggressive non-mycosis fungoides/Sézary syndrome subtypes (n = 9). The median survival times in these 3 groups were 118.7, 45.7 and 11.2 months, respectively, and the 5-year survival rates were 55.3%, 27.8% and 33.3%, respectively. Multivariate analyses in patients with mycosis fungoides/Sézary syndrome identified age ≥ 70 years, Eastern Cooperative Oncology Group Performance Status ≥ 2, and the high-risk group according to the Cutaneous Lymphoma International Consortium prognostic model, as adverse prognostic factors. Seven patients in this mycosis fungoides/Sézary syndrome group were in complete long-term remission after treatment with bexarotene, including 4 patients living without any treatment for 16–101 months.

Dates and versions

hal-03602605 , version 1 (09-03-2022)

Identifiers

Cite

Joséphine Franceschi, Marine Ehret, Laetitia Visseaux, Anne Durlach, Coralie Barbe, et al.. Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas. Acta Dermato-Venereologica, 2022, ⟨10.2340/actadv.v102.1087⟩. ⟨hal-03602605⟩

Collections

URCA P3CELL
10 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More